Quick Answer
ARTELO BIOSCIENCES, INC. reported Net Income Loss of -$12.88 million for the year ending 2025.
- ARTELO BIOSCIENCES, INC. showed a decrease of -31.1% in Net Income Loss from 2024 to 2025.
- This data is from ARTELO BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2014 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2014 to 2025), ARTELO BIOSCIENCES, INC.'s Net Income Loss has declined by 84,247.4%.
- Historical annual values: Fiscal year 2025: -$12.88 million | Fiscal year 2024: -$9.83 million | Fiscal year 2023: -$9.29 million | Fiscal year 2022: -$10.08 million | Fiscal year 2021: -$9.41 million | Fiscal year 2021: -$7.44 million | Fiscal year 2020: -$4.66 million | Fiscal year 2019: -$2.17 million | Fiscal year 2018: -$2.34 million | Fiscal year 2017: -$234.9 thousand | Fiscal year 2016: -$29.7 thousand | Fiscal year 2015: -$15.2 thousand | Fiscal year 2014: -$15.3 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: